March 5 (Reuters) - MiniMed, the diabetes business of medical device maker Medtronic MDT.N, said on Thursday it has raised $560 million in its U.S. initial public offering.
(Reporting by Manya Saini in Bengaluru and Carlos Méndez in Mexico City; Editing by Sumana Nandy and Sahal Muhammed)
((Manya.Saini@thomsonreuters.com; X: manya__saini;))